Variability in blood pressure predicts cardiovascular disease in young- and middle-aged subjects, but relevant data for older individuals are sparse. We analysed data from the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER) study of 5804 participants aged 70–82 years with a history of, or risk factors for cardiovascular disease. Visit-to-visit variability in blood pressure (standard deviation) was determined using a minimum of five measurements over 1 year; an inception cohort of 4819 subjects had subsequent in-trial 3 years follow-up; longer-term follow-up (mean 7.1 years) was available for 1808 subjects. Higher systolic blood pressure variability independently predicted long-term follow-up vascular and total mortality (h...
BACKGROUND: In older age, a low DBP has been associated with increased risk of cardiovascular events...
Background: PROSPER was designed to investigate the benefits of treatment with pravastatin in elderl...
Background Although statins reduce coronary and cerebrovascular morbidity and mortality in middle-ag...
Variability in blood pressure predicts cardiovascular disease in young- and middle-aged subjects, bu...
Variability in blood pressure predicts cardiovascular disease in young- and middle-aged subjects, bu...
BACKGROUND: Visit-to-visit variability in blood pressure is an independent predictor of cardiovascul...
Obectives: In hypertensive persons aged 60 years or below, visit-to-visit SBP variability is directl...
High office blood pressure variability (OBPV) in midlife increases the risk of cardiovascular diseas...
Background: Information is scarce regarding effects of antihypertensive medication on blood pressure...
OBJECTIVE: To investigate whether baseline systolic blood pressure variability was a risk factor for...
Background: Information is scarce regarding effects of antihypertensive medication on blood pressure...
Objectives: Blood pressure is a long-established risk factor for cardiovascular disease. Systolic b...
Background Information is scarce regarding effects of antihypertensive medication on blood pressure ...
Aims Blood pressure variability is associated with increased risk of cardiovascular events, particul...
Objective To systematically review studies quantifying the associations of long term (clinic), mid-t...
BACKGROUND: In older age, a low DBP has been associated with increased risk of cardiovascular events...
Background: PROSPER was designed to investigate the benefits of treatment with pravastatin in elderl...
Background Although statins reduce coronary and cerebrovascular morbidity and mortality in middle-ag...
Variability in blood pressure predicts cardiovascular disease in young- and middle-aged subjects, bu...
Variability in blood pressure predicts cardiovascular disease in young- and middle-aged subjects, bu...
BACKGROUND: Visit-to-visit variability in blood pressure is an independent predictor of cardiovascul...
Obectives: In hypertensive persons aged 60 years or below, visit-to-visit SBP variability is directl...
High office blood pressure variability (OBPV) in midlife increases the risk of cardiovascular diseas...
Background: Information is scarce regarding effects of antihypertensive medication on blood pressure...
OBJECTIVE: To investigate whether baseline systolic blood pressure variability was a risk factor for...
Background: Information is scarce regarding effects of antihypertensive medication on blood pressure...
Objectives: Blood pressure is a long-established risk factor for cardiovascular disease. Systolic b...
Background Information is scarce regarding effects of antihypertensive medication on blood pressure ...
Aims Blood pressure variability is associated with increased risk of cardiovascular events, particul...
Objective To systematically review studies quantifying the associations of long term (clinic), mid-t...
BACKGROUND: In older age, a low DBP has been associated with increased risk of cardiovascular events...
Background: PROSPER was designed to investigate the benefits of treatment with pravastatin in elderl...
Background Although statins reduce coronary and cerebrovascular morbidity and mortality in middle-ag...